Hubei Jumpcan Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hubei Jumpcan Pharmaceutical Co Ltd with three other
companies in this sector in China:
Tong Ren Tang Technologies Company Limited
sales of 4.67 billion Chinese Renmimbi [US$678.80 million]
KPC Pharmaceuticals Inc
(5.10 billion Chinese Renmimbi [US$742.14 million]
of which 47%
was Drugs Wholesale and Retail), and
China Medical System Holdings Limited
(4.90 billion Chinese Renmimbi [US$713.07 million]
Hubei Jumpcan Pharmaceutical Co Ltd reported sales of 4.68 billion Chinese Renmimbi (US$680.62 million)
December of 2016.
increase of 25.0%
versus 2015, when the company's sales were 3.74 billion Chinese Renmimbi.
This was the fourth straight year of sales growth at Hubei Jumpcan Pharmaceutical Co Ltd.
Sales of Industrial Manufacturing saw an increase
25.5% in 2016, from
3.59 billion Chinese Renmimbi to 4.51 billion Chinese Renmimbi.
Not all segments of Hubei Jumpcan Pharmaceutical Co Ltd experienced an increase in sales in 2016:
sales of Trade fell 4.4% to 160.50 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).